First Mercantile Trust’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$233K	Sell	4,159 -285	-6%	-$16.4K	0.03%	363
2021 Q2	$270K	Sell	4,444 -246	-5%	-$15.6K	0.03%	320
2021 Q1	$329K	Sell	4,690 -1,835	-28%	-$131K	0.04%	268
2020 Q4	$390K	Sell	6,525 -522	-7%	-$30.6K	0.04%	233
2020 Q3	$404K	Sell	7,047 -273	-4%	-$15.9K	0.05%	208
2020 Q2	$384K	Buy	7,320 +1,101	+18%	+$46K	0.05%	223
2020 Q1	$209K	Sell	6,219 -994	-14%	-$41.3K	0.03%	328
2019 Q4	$327K	Sell	7,213 -173	-2%	-$7.35K	0.04%	317
2019 Q3	$281K	Buy	7,386 +2,923	+65%	+$117K	0.03%	377
2019 Q2	$194K	Buy	4,463 +728	+19%	+$30.9K	0.02%	454
2019 Q1	$142K	Buy	+3,735	New	+$146K	0.03%	566
2016 Q2	–	Sell	-9,303	Closed	-$493K	–	910
2016 Q1	$493K	Sell	9,303 -1,000	-10%	-$58.5K	0.06%	382
2015 Q4	$791K	Buy	+10,303	New	+$583K	0.08%	307
2015 Q1	–	Sell	-4,463	Closed	-$395K	–	1115
2014 Q4	$395K	Sell	4,463 -10,845	-71%	-$1.03M	0.03%	566
2014 Q3	$1.48M	Sell	15,308 -3,980	-21%	-$387K	0.12%	212
2014 Q2	$1.77M	Buy	19,288 +4,538	+31%	+$346K	0.14%	188
2014 Q1	$1.03M	Buy	14,750 +6,850	+87%	+$466K	0.08%	358
2013 Q4	$454K	Sell	7,900 -300	-4%	-$15.8K	0.04%	586
2013 Q3	$394K	Buy	+8,200	New	+$299K	0.03%	613